estrogen receptor Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (3)
Any (1)

Phase 1 (1)
Phase 2 (1)
Unknown (2)

Interventional (2)
Observational (2)

H3 Biomedicine Inc. (1)
Jilin University (1)
Sanofi (1)
UNICANCER (1)

No (4)

No (4)

Adult (18+) (4)

I am/have/had

I am/have/hadadvanced breast cancer

I am/have/hadHER2

I am/have/hadadenocarcinoma of the breast

I am/have/hadepidermal growth factor receptor

I am/have/hadffpe

I am/have/hadtargeted therapy

I am/have/hadcancer

I am/have/hadestrogen receptor

I am/have/hadestrogen receptor-positive breast cancer

I am/have/hadstage iv breast cancer

I am/have/hadmetastasis

I am/have/hadimmunohistochemistry

I am/have/haderbb1

I am/have/hadbreast cancer

I am/have/hadadenocarcinoma

I am/have/hadcancer metastatic

I am/have/hadher2/neu-negative breast cancer

I am/have/hadinvasive breast cancer

I am/have/hadlocally advanced breast cancer

I am/have/hadestrogen receptor positive breast cancer

added new label for I am/have/had

more

I am looking for

I am looking forpalbociclib

I am looking forimmunological adjuvant

I am looking forfulvestrant

I am looking forexemestane

I am looking forestrogen

I am looking foradjuvant

I am looking forendocrine therapy

I am looking forletrozole

I am looking forepidermal growth factor

I am looking forhormone therapy

I am looking fortamoxifen

I am looking foranastrozole

I am looking forgrowth factor

added new label for I am looking for

more

Advanced Filters

Loading...

Found 181 clinical trials

For Seniors
For adults
Recruiting in 100s
Observational Study
For Females
Recruiting

Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer

Retrospective observational, multicentric study assessing the immunohistochemistry (IHC) based test IHC4 score in infiltrating early breast cancer: comparison of the score performed in local laboratory vs in a central laboratory and concordance with a molecular gold standard classifier (EndoPredict).

immunohistochemistry

invasive breast cancer

HER2

er-positive breast cancer

ffpe

0 views
19 Feb, 2024
1 location

14
15
16
17
18
19

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.